glp-1 semaglutide and tirzepatide GLP-1² Advanced Weight Loss Therapy Semaglutide and Tirzepatide for Weight

Compounding pharmacies often provide semaglutide in different concentrations, requiring conversion calculations

For individuals with obesity, calculating protein needs based on an estimated reference body weight (for example, the weight corresponding to a BMI of 25 kg/m for your height) rather than actual body weight may be more appropriate, as using actual weight can overestimate requirements

By activating all three together, the drug may reduce appetite, help burn more calories and improve blood sugar control

Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection